RAINBOW: A global, phase III, randomized, double-blind study of ramucirumab plus paclitaxel versus placebo plus paclitaxel patients with previously treated gastric or gastroesophageal junction (GEJ) adenocarcinoma: Quality-of-life (QoL) results.
暂无分享，去创建一个
Tae-You Kim | N. Sugimoto | G. Bodoky | P. Rougier | D. Cunningham | S. Oh | K. Muro | A. Ohtsu | S. Al-Batran | Y. Shimada | E. Cutsem | O. Lipatov | H. Wilke | S. Hironaka | A. Liepa | M. Emig | S. Ballal